KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Change in Inventory (2016 - 2026)

Bristol Myers Squibb has reported Change in Inventory over the past 18 years, most recently at -$14.0 million for Q1 2026.

  • Quarterly Change in Inventory fell 108.28% to -$14.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Mar 2026, down 99.77% year-over-year, with the annual reading at $184.0 million for FY2025, 62.14% down from the prior year.
  • Change in Inventory was -$14.0 million for Q1 2026 at Bristol Myers Squibb, up from -$71.0 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $282.0 million in Q1 2023 and troughed at -$175.0 million in Q4 2024.
  • The 5-year median for Change in Inventory is $41.0 million (2022), against an average of $86.8 million.
  • Year-over-year, Change in Inventory skyrocketed 28300.0% in 2023 and then plummeted 188.83% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $41.0 million in 2022, then surged by 380.49% to $197.0 million in 2023, then crashed by 188.83% to -$175.0 million in 2024, then skyrocketed by 59.43% to -$71.0 million in 2025, then surged by 80.28% to -$14.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Change in Inventory are -$14.0 million (Q1 2026), -$71.0 million (Q4 2025), and $90.0 million (Q3 2025).